The menopausal transition does not appear to accelerate age-related increases in arterial stiffness

S M O'Neill1, J Liu, M F O'Rourke

  • 1Betty Byrne Henderson Women's Health Research Centre, Royal Brisbane & Women's Hospital, Brisbane and the University of Queensland, Australia.

Insights

Menopause does not appear to accelerate age-related arterial stiffness. This study found no significant differences in arterial stiffness measures between menopause groups, challenging previous assertions.

Area of Science:

  • Cardiovascular Physiology
  • Women's Health
  • Aging Research

Background:

  • Arterial stiffness is a key cardiovascular risk factor, increasing with age, hypertension, diabetes, and hyperlipidemia.
  • While arterial stiffness is known to increase with age and is more pronounced in women, the specific impact of menopause remains debated.

Purpose of the Study:

  • To investigate whether menopause accelerates age-dependent changes in arterial stiffness.
  • To evaluate the relationship between menopausal status and arterial stiffness markers.

Main Methods:

  • Applanation tonometry was used to assess pulse wave analysis and pulse wave velocity in 468 women aged 40-80.
  • Multiple linear regression models identified age as the primary correlate of increased aortic augmentation pressure, augmentation index, and carotid-femoral pulse wave velocity.

Main Results:

  • No significant differences in adjusted mean augmentation pressure, augmentation index, or pulse wave velocity were found between pre-, peri-, and postmenopausal women.
  • Arterial stiffness measures were comparable between women using hormone therapy and non-users.

Conclusions:

  • The study findings challenge the notion that menopause accelerates age-dependent arterial stiffness.
  • Age, rather than menopausal status, appears to be the dominant factor influencing arterial stiffness in women within this age range.
Abstract

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...